Isovaleric acidemia is a rare inherited metabolic disorder of the organic acidemias that results from deficiency of the enzyme isovaleric co-amylase (IVA), which is essential for the catabolism of the amino acid leucine. The disorder results in accumulation of isovaleric acid and other metabolites, which can cause severe clinical manifestations including metabolic crisis, neurological dysfunction and, in severe cases, death. Isovaleric acidemia may present in childhood or later in life, but most cases are diagnosed in the neonatal period through screening programs.
History of the disease and interesting historical facts
Isovaleric acidemia was first described in 1962, when specialists began to associate similar clinical manifestations with disorders of amino acid metabolism. In parallel with the development of molecular biology and genetics technologies, it became clear that this disease is caused by a specific mutation in the gene encoding the enzyme responsible for leucine metabolism. Interestingly, since the description of the disease, it took several decades to determine the exact molecular nature and mechanisms of its development. Scientific research continues, and new technologies allow us to better understand its pathophysiology, which opens up new horizons in the treatment of patients.
Epidemiology
Isovaleric acidemia is estimated to occur at a rate of approximately 1 in 250,000 live births. However, this figure may vary by population and ethnicity. It is important to note that in some groups, such as those from countries with high levels of genetic diversity, the incidence may be higher, such as approximately 1 in 100,000. Because the disease can be asymptomatic, its true prevalence may be underestimated, and many cases go undiagnosed without newborn screening.
Genetic predisposition to this disease
Isovaleric acidemia is caused by mutations in the IVD gene, which is located on chromosome 19 and codes for isovaleric co-alimase. In most cases, the disease is autosomal recessive, meaning that both parents must be carriers of the mutant gene for symptoms to occur. More than 50 different mutations in this gene have been identified across populations, highlighting the genetic heterogeneity of the disease. Genetic testing and molecular genetic analysis play a key role in diagnosis and predicting the prognosis for affected families.
Risk factors for the development of this disease
Risk factors for isovaleric acidemia can be divided into the following categories:
- Heredity: Having a family history of the disease is the main risk factor.
- Ethnicity: Increased susceptibility is seen among certain ethnic groups.
- Age: Symptoms may appear in early childhood or later in life.
- Environmental factors: Although specific chemical or physical triggers have not yet been identified, some studies suggest possible effects from toxic substances, but more data is needed to confirm this.
Diagnosis of this disease
Diagnosis of isovaleric acidemia begins with a clinical evaluation. The main symptoms of the disease include:
- Metabolic crisis: manifested by severe food intolerance, vomiting, lethargy, convulsions.
- Neurological disorders: altered consciousness, hypotension or hypertension may occur.
- Fragrant odor of sweat: The specific odor of altered sweat is a characteristic sign.
Laboratory studies include serum and urinary isovaleric acid levels. Radiologic studies such as MRI may help exclude other neurologic disorders that require differential diagnosis. Differential diagnosis includes other organic acidemias and metabolic disorders.
Treatment
Treatment of isovaleric acidemia involves several key aspects:
- General treatment: A leucine-restricted diet and replacement therapy are necessary to prevent the accumulation of toxic metabolites.
- Pharmacological treatment: The use of citrates and special supplements such as carnitine may be helpful in managing the condition.
- Surgical treatment: In rare cases, surgery may be necessary to repair damage associated with the disease.
- Other treatments include genetic counselling and supportive care by a multidisciplinary team.
List of medications used to treat this disease
Among the recommended drugs for the treatment of isovaleric acidemia are:
- Levocarnitine
- Calcium Citrate
- Coenzyme A
- Low Leucine Amino Acid Supplements
Disease monitoring
Monitoring of patients with isovaleric acidemia includes:
- Routine laboratory tests: monitoring metabolite levels and blood tests.
- Prognosis: With diet and medical advice, many patients can lead normal lives.
- Complications: Without adequate treatment, serious neurological disorders and metabolic crisis may occur.
Age-related features of the disease
The manifestations of isovaleric acidemia may vary depending on the age of the patient. In newborns, acute metabolic crises are observed, which require immediate intervention. In childhood, the manifestations may become less pronounced, but cases of relapse and crisis are still possible. In adult patients, the disease may manifest itself in a chronic form, with periodic exacerbations associated with dietary errors or viral infections.
Questions and Answers
- What are the main symptoms of isovaleric acidemia? The main symptoms include metabolic crisis, neurological disorders and a specific odor of sweat.
- How is the disease diagnosed? Diagnosis is based on laboratory tests specializing in the determination of isovaleric acid, as well as clinical examination.
- What is the treatment for isovaleric acidemia? Treatment includes a leucine-restricted diet, pharmacologic therapy, and, in rare cases, surgery.
- What is the prognosis for patients with this disease? By following medical recommendations and diet, patients can lead normal lives, although the risk of complications remains.
- What is the genetic predisposition to the disease? Isovaleric acidemia is an autosomal recessive disorder associated with mutations in the IVD gene.
According to Dr. Oleg Korzhikov, if there is a hereditary predisposition to isovaleric acidemia, it is important to conduct early diagnostics and regular examination of newborns. Parents should pay attention to changes in the child's behavior and health, especially in the first months of life. In addition, it is recommended to seek genetic counseling for more detailed information and recommendations.
